The University of British Columbia
UBC - A Place of Mind
The University of British Columbia Vancouver campus
Neglected Global Diseases Initiative (NGDI-UBC)
  • Home
  • About Us
    • Neglected Global Diseases
    • Our Mission
    • Leadership and Advisory Board
    • Partners
    • Annual Reports
    • Media Centre
    • Contact Us
  • Research
    • Neglected Tropical Diseases
    • HIV/AIDS, Malaria and Tuberculosis
    • Other Diseases and Conditions
    • Antiobiotic Resistance, Vaccines & Diagnostics
    • Health Policy
    • Ebola Information
  • Delivery Model
    • Model of Collaboration
    • Drug Discovery
    • Drug Development
    • Vector control, Tools & Diagnostics
    • Supply Chain
    • Health Systems Research
    • Implementation Research
    • Operational Research
    • Policy Work on Affordability & Adoption
  • Knowledge Mobilization
    • Ebola Information
    • Distinguished Lectureship Seminar Series
    • NGDI Student Global Health Journal
    • Student Projects
    • Past Events
    • Funding Opportunities
    • Reports of Interest
  • Recent News
    • Events
    • Education
    • Funding
    • Initiative
    • News
    • Projects
  • Global Health Online Network
  • Donate
» Home » NGDI Members Urs Hafeli and Tobias Kollmann have received new grant funding for novel vaccine technology

NGDI Members Urs Hafeli and Tobias Kollmann have received new grant funding for novel vaccine technology

2013-04-08

NGDI congratulates the Transcutaneous Microsphere Vaccine Technology team headed by Dr. Jan Dutz from the Skin Care Centre at BC Children’s Hospital.

Co-investigators are Dr. Urs Hafeli, Dr. Tobias Kollmann, and Dr. Boris Stoeber. The three-year grant is for $600,000 and is funded through the CIHR/NSERC Collaborative Health Research Projects.  The abstract for the project is below:

Common “killed” microbe vaccines such as hepatitis vaccine, must be given repeatedly to be effective. Influenza vaccine must be given yearly. This is costly and inconvenient. In recent work we have shown that vaccines can be incorporated into dissolving spheres that release bursts of vaccine in the skin at timed intervals. We will use this system to obtain the same effect as repeated administration, but with a single administration. The spheres will be delivered into the skin painlessly using new microscopic hollow needles that allow painless administration. We plan to optimize this new method of vaccination by combining the skills of an immunologist, a pharmacy scientist, a mechanical engineer and a clinical vaccinologist. The projected advantages of this new vaccine system are lowered cost, pain free administration, and increased efficacy.

  • Previous
  • Next

Tweet

Tags Search

Neglected Global Diseases Initiative
Vancouver Campus
564 - 828 West 10th Avenue
Vancouver, BC Canada V5Z 1L8
Website ngdi.ubc.ca
Email info.ngdi@ubc.ca
Find us on
  
Back to top
The University of British Columbia
  • Emergency Procedures |
  • Terms of Use |
  • Copyright |
  • Accessibility